Compare ASYS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASYS | BDSX |
|---|---|---|
| Founded | 1981 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.3M | 276.2M |
| IPO Year | 2006 | 2020 |
| Metric | ASYS | BDSX |
|---|---|---|
| Price | $14.98 | $28.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | ★ 304.0K | 88.8K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $79,364,000.00 | ★ $88,499,000.00 |
| Revenue This Year | $2.82 | $25.26 |
| Revenue Next Year | $18.75 | $19.15 |
| P/E Ratio | $74.89 | ★ N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $6.75 | $5.26 |
| 52 Week High | $25.71 | $31.31 |
| Indicator | ASYS | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 57.31 |
| Support Level | $13.69 | $19.26 |
| Resistance Level | $15.87 | $31.31 |
| Average True Range (ATR) | 0.63 | 1.67 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 74.41 | 68.92 |
Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.